Investor Relations (IR) Questions: Bacterin International BONE
Click here to return to the biotech IRQ Index
Answers received: September 2012
I’ve answered below the questions you posed to Guy Cook, our CEO
- The Company raised $3.9mm in equity during the 1q of 2012 through an equity line of credit we had in place with Licoln Park Capital. The line was terminated in March 2012.
- We currently have approximately $9mm in cash. No existing credit line.
- No known catalyst or clinical trial result we are waiting on. Focusing on executing our growth stategy and increase revenues and profits
- Last quarter the Company was approximately EBITDA (cash flow) breakeven.
John Gandolfo
Chief Financial Officer
I’ve answered below the questions you posed to Guy Cook, our CEO
- The Company raised $3.9mm in equity during the 1q of 2012 through an equity line of credit we had in place with Licoln Park Capital. The line was terminated in March 2012.
- We currently have approximately $9mm in cash. No existing credit line.
- No known catalyst or clinical trial result we are waiting on. Focusing on executing our growth stategy and increase revenues and profits
- Last quarter the Company was approximately EBITDA (cash flow) breakeven.
John Gandolfo
Chief Financial Officer